Introducing The Pioneering XTRAC Velocity™ Excimer Laser: Delivers Psoriasis And Vitiligo Treatments Three Times Faster
Main Category: DermatologyArticle Date: 02 Jun 2009 - 8:00 PDT
| Patient / Public: | ![]() |
|
| Health Professional: | ![]() |
4.5 (2 votes) |
| Article Opinions: | 0 posts |
PhotoMedex, Inc. (NASDAQ: PHMD), a leader in the development of proprietary excimer laser and fiber optic systems as well as other products for dermatological applications, announced the availability of its groundbreaking XTRAC Velocity™ Excimer Laser, a device expected to redefine laser treatment options for patients suffering from psoriasis and vitiligo.
Two separate independent third-party agencies have confirmed that the XTRAC Ultra® laser, precursor to the XTRAC Velocity excimer laser, is the most accurate, powerful, and fastest excimer laser available to date. PhotoMedex has raised the bar even higher with the Velocity laser, which features an average laser power of up to 7.2 watts delivered to the patient. Velocity's treatment time is nearly three times faster than PhotoMedex' XTRAC Ultra laser. In performance tests the device has been able to treat lesions of 3,500 cm2 (600 mj/cm2) in 4 minutes, 52 seconds*-roughly 1/3 the time required by the Ultra.
Because the innovative Velocity excimer laser can cover a much greater surface area in the average treatment session-up to 20% of the body surface in five minutes versus only 2 to 4% for alternative lasers-it is the first practical alternative to potent pharmaceuticals or full-body UV irradiation for patients with severe psoriasis.
"The XTRAC Velocity laser is going to be a game-changer for patients and dermatology practices alike," said Jeff O'Donnell, president of PhotoMedex. "For patients, the Velocity will dramatically shorten treatment times, increase the size and number of lesions that can be treated per session, and open laser therapy as a viable alternative for patients who were not necessarily laser candidates in the past. In fact, for busy dermatology practices, the Velocity will make it practical to treat as many as 32 patients per day."
New Touchscreen, Handpiece Controls
With a maximum repetition rate of 400 Hz and delivered laser energy of 12 to 18 millijoules/pulse, PhotoMedex' XTRAC Velocity is unparalleled in its power and treatment speed. The new laser system has an unparalleled safety profile and is also highly effective with a long duration of remission-yet laser performance is only the beginning of the unit's advantages.
To increase quality of care for patients as well as increase the clinician's convenience, the Velocity offers a new full-color touchscreen control interface. The screen and built-in database tracking software goes beyond normal equipment operation to incorporate patient information including ID generation, recognition, treatment history, dosing heuristics and more. Also included for the first time on the Velocity is a touch control handpiece that allows the laser treatment to be delivered more easily compared to conventional footswitch-controlled devices.
"Profit Per Treatment" Model
Like all the excimer lasers in the PhotoMedex line, the Velocity is available to clinics at no direct cost via a unique consignment-based business model. Thanks to the "Profit per Treatment" model, dermatologists provide Velocity laser therapy to their customers, paying a fee only on treatments rendered. In-service training is provided by a dedicated PhotoMedex clinical specialist. Reimbursement support is also provided by a team of direct employee-insurance specialists who continue to receive positive reviews from both office staff and patients for their dedicated and knowledgeable support. Purchase options and financing for PhotoMedex lasers are available as well.
* Treatment time calculations do not include the overhead associated with moving the hand piece.
Source
PhotoMedex
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2009 MediLexicon International Ltd |





